Damora Therapeutics (DMRA) Prepaid Assets (2019 - 2026)
Damora Therapeutics (DMRA) reported Prepaid Assets of $2.5 million for Q1 2026, up 507.51% on a YoY basis from $413000.0 in Q1 2025, and up 334.84% quarter-over-quarter from $577000.0 in Q4 2025.
Damora Therapeutics (DMRA) Prepaid Assets (2019 - 2026) Analysis & Trends
Damora Therapeutics has reported Prepaid Assets for 8 years, with the latest figure at $2.5 million in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets rose 507.51% year-over-year to $2.5 million; the trailing twelve-month figure through Mar 2026 stood at $2.5 million (up 507.51% YoY), and the FY2025 full-year result was $577000.0, down 2.2% from the prior year.
- Prepaid Assets for Q1 2026 stood at $2.5 million, up from $577000.0 in the prior quarter.
- The five-year high for Prepaid Assets was $3.9 million in Q1 2023, with the low at $52000.0 in Q4 2022.
- Historically, Prepaid Assets has averaged $1.3 million across 5 years, with a median of $577000.0 in 2025.
- Annual changes were most pronounced in 2023 — Prepaid Assets surged 1446.22% — and 2024, when it tumbled 96.91%.
- Damora Therapeutics' Prepaid Assets stood at $52000.0 in 2022, then surged by 1388.46% to $774000.0 in 2023, then retreated by 23.77% to $590000.0 in 2024, then declined by 2.2% to $577000.0 in 2025, then jumped by 334.84% to $2.5 million in 2026.
- The last three Prepaid Assets figures came in at $2.5 million (Q1 2026), $577000.0 (Q4 2025), and $56000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Damora Therapeutics | 731.26 Mn | 528.86 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.51 Mn |
| Dec 31, 2025 | 577,000.00 |
| Sep 30, 2025 | 56,000.00 |
| Jun 30, 2025 | 232,000.00 |
| Mar 31, 2025 | 413,000.00 |
| Dec 31, 2024 | 590,000.00 |
| Sep 30, 2024 | 89,000.00 |
| Jun 30, 2024 | 2.31 Mn |
| Mar 31, 2024 | 189,000.00 |
| Dec 31, 2023 | 774,000.00 |
| Sep 30, 2023 | 2.88 Mn |
| Jun 30, 2023 | 3.24 Mn |
| Mar 31, 2023 | 3.88 Mn |
| Dec 31, 2022 | 52,000.00 |
| Sep 30, 2022 | 214,000.00 |
| Jun 30, 2022 | 3.18 Mn |
| Mar 31, 2022 | 251,000.00 |
| Dec 31, 2021 | 334,000.00 |
| Sep 30, 2021 | 4.86 Mn |
| Jun 30, 2021 | 665,000.00 |